Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (271-280 of 342) with videos related to

Pageof 35
Sort By:
European Heart Journal|January 17, 2023
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk scoreMaria A de Winter, Harry R Büller, Marc Carrier, et al.
Journal of the American College of Cardiology|November 3, 2022
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized TrialsCandrika D Khairani, Antoine Bejjani, Gregory Piazza, et al.
Blood|September 22, 2018
Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosisElham E Amin, Ingrid M Bistervels, Karina Meijer, et al.
Lancet (London, England)|November 10, 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trialIngrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysisMaria A de Winter, Alicia Uijl, Harry R Büller, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2021
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 29, 2023
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial FibrillationSabine F B van der Horst, Tim A C de Vries, Gordon Chu, et al.
European Journal of Neurology|July 22, 2021
Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines AgencyKatarzyna Krzywicka, Mirjam R Heldner, Mayte Sánchez van Kammen, et al.
The European Respiratory Journal|November 16, 2019
Clinical implications of incidental venous thromboembolism in cancer patientsFrits I Mulder, Marcello Di Nisio, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2024
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Donald M Arnold, Charlotte A Bradbury, et al.
Pageof 35

Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
European Heart Journal|January 17, 2023
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk scoreMaria A de Winter, Harry R Büller, Marc Carrier, et al.
Journal of the American College of Cardiology|November 3, 2022
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized TrialsCandrika D Khairani, Antoine Bejjani, Gregory Piazza, et al.
Blood|September 22, 2018
Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosisElham E Amin, Ingrid M Bistervels, Karina Meijer, et al.
Lancet (London, England)|November 10, 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trialIngrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysisMaria A de Winter, Alicia Uijl, Harry R Büller, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2021
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 29, 2023
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial FibrillationSabine F B van der Horst, Tim A C de Vries, Gordon Chu, et al.
European Journal of Neurology|July 22, 2021
Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines AgencyKatarzyna Krzywicka, Mirjam R Heldner, Mayte Sánchez van Kammen, et al.
The European Respiratory Journal|November 16, 2019
Clinical implications of incidental venous thromboembolism in cancer patientsFrits I Mulder, Marcello Di Nisio, Cihan Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2024
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Donald M Arnold, Charlotte A Bradbury, et al.
Pageof 35